Article Text
Abstract
To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0–10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0–10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.
- Consensus
- Achilles Tendon
- Tendinopathy
- Review
Statistics from Altmetric.com
Footnotes
X @rj_devos, @DrPeteMalliaras, @SIDocking, @shawnhanlonATC, @pdkirwan, @ajmallows1, @DrDylanM, @myles_physio, @tendonpain, @sancho_igor, @Pat_Vallance, @ArcoVlist, @Bill_Vicenzino
R-JdV, KGS, PM and TSV contributed equally.
Contributors R-JdV: guarantor R-JdV, KGS, PM and TSV: concept, project lead, methods, data collection and analysis, writing. BV: project oversight, methods, writing. Achilles working group and expert panel of professional participants: design, Delphi process, patient inclusion, writing.
Funding The authors from the steering group (R-JdV, KGS, PM and BV) have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Within this 5-year project, multiple authors have been supported by specific research fellowships and/or grants that were not directly related to the COS-AT development. One author (DM) mentioned indirect support by the National Institute for Health Research Barts Biomedical Research Centre (NIHR203330).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.